Search details
1.
Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.
Am J Respir Crit Care Med
; 204(11): 1306-1316, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34464235
2.
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
J Surg Oncol
; 120(7): 1276-1283, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31602665
3.
Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
J Am Acad Dermatol
; 80(6): 1640-1649, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30654077
4.
Immune checkpoint inhibitors in NSCLC.
Curr Treat Options Oncol
; 15(4): 658-69, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25096781
5.
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.
J Immunother Cancer
; 12(6)2024 Jun 06.
Article
in English
| MEDLINE | ID: mdl-38844408
6.
Implementing Real-World RECIST-based Tumor Response Assessment in Patients With Metastatic Non-small Cell Lung Cancer.
Clin Lung Cancer
; 23(3): 191-194, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35283071
7.
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Nat Med
; 28(11): 2364-2373, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36229663
8.
TORC1 is essential for NF1-associated malignancies.
Curr Biol
; 18(1): 56-62, 2008 Jan 08.
Article
in English
| MEDLINE | ID: mdl-18164202
9.
Customizable Natural Language Processing Biomarker Extraction Tool.
JCO Clin Cancer Inform
; 5: 833-841, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34406803
10.
Validation of a Mortality Composite Score in the Real-World Setting: Overcoming Source-Specific Disparities and Biases.
JCO Clin Cancer Inform
; 5: 401-413, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33830788
11.
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.
Cancers (Basel)
; 12(8)2020 Aug 13.
Article
in English
| MEDLINE | ID: mdl-32823698
12.
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
Pharmacogenomics
; 21(6): 375-386, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32077359
13.
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.
Cancers (Basel)
; 12(7)2020 Jul 17.
Article
in English
| MEDLINE | ID: mdl-32708981
14.
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis.
Sci Rep
; 10(1): 17536, 2020 10 16.
Article
in English
| MEDLINE | ID: mdl-33067482
15.
Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium.
Mol Cancer Ther
; 7(2): 418-24, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-18245671
16.
ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.
Mol Cancer Ther
; 17(1): 222-231, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29054983
17.
Pragmatic precision oncology: the secondary uses of clinical tumor molecular profiling.
J Am Med Inform Assoc
; 23(4): 773-6, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27026612
18.
Implementing and Improving Automated Electronic Tumor Molecular Profiling.
J Oncol Pract
; 12(3): e332-7, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26813927
19.
SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care.
J Am Med Inform Assoc
; 23(4): 701-10, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27018265
20.
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.
Cancer Immunol Res
; 4(11): 959-967, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27671167